Article
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
BMC cancer - 9 Sept 2016
Grasso Carole, Anaka Matthew, Hofmann Oliver, Sompallae Ramakrishna, Broadley Kate, Hide Winston, Berridge Michael V, Cebon Jonathan, Behren Andreas, McConnell Melanie J
Abstract excerpt
BACKGROUND: The heterogeneity and tumourigenicity of metastatic melanoma is attributed to a cancer stem cell model, with CD133 considered to be a cancer stem cell marker in melanoma as well as other tumours, but its role has remained controversial. METHODS: We iteratively sorted CD133+ and CD133- cells from 3 metastatic melanoma cell lines, and observed tumourigenicity and phenotypic characteristics over 7...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
